U.S. Markets closed

INSYS Therapeutics, Inc. (INSY)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
9.17-0.11 (-1.19%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close9.28
Bid9.00 x 100
Ask10.44 x 600
Day's Range9.03 - 9.27
52 Week Range8.70 - 18.42
Avg. Volume614,836
Market Cap661.43M
PE Ratio (TTM)-509.44
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 3 Top Biotech Stocks Under $10
    Motley Foolyesterday

    3 Top Biotech Stocks Under $10

    Celldex Therapeutics, Insys Therapeutics, and Novavax might not be so cheap over the long run.

  • Reuters2 days ago

    Insys agrees to pay $4.45 mln to resolve Illinois opioid lawsuit

    Insys Therapeutics Inc has agreed to pay $4.45 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed an addictive fentanyl-based cancer pain drug for off-label uses. The settlement, announced by Illinois Attorney General Lisa Madigan on Friday, will resolve claims that Insys illegally marketed its product Subsys to high-volume prescribers of opioid drugs instead of to oncologists treating cancer patients. "It's unethical, greedy behavior by companies like Insys that is responsible for creating the opioid epidemic and resulting overdose deaths in our state," Madigan said in a statement.

  • This Struggling Marijuana Stock Finally Launched Its Highly Anticipated Drug
    Motley Fool6 days ago

    This Struggling Marijuana Stock Finally Launched Its Highly Anticipated Drug

    Can this synthetic version of THC reinvigorate sales for a pot stock whose shares have fallen by roughly 80% in two years?